Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc.’s (NASDAQ: ILMN) NextSeq™ 550Dx platform and associated reagent kits received medical device registration in Russia, as have reagents for the MiSeq™Dx which was approved previously as a medical device. Both of these in vitro diagnostic (IVD)-ready solutions are available to customers and third-party developers to create diagnostic solutions using the technology.... Read more

Danaher To Present At Barclays Global Healthcare Conference

WASHINGTON, March 4, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that Executive Vice President and Chief Financial Officer, Matt McGrew, will be presenting at the Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 11:30 a.m. ET. The audio will be simultaneously webcast on www.danaher.com. ABOUT DANAHERDanaher is a global science and technology innovator... Read more

Nalgene Outdoor Increases Its Commitment to Manufacturing with Recycled Materials; New Products Kickoff Year-Long Goal to Convert All Bottle Production to Tritan Renew

Nalgene Outdoor Increases Its Commitment to Manufacturing with Recycled Materials; New Products Kickoff Year-Long Goal to Convert All Bottle Production to Tritan Renew Expanded styles and sizes of Nalgene Sustain line made from 50% recycled material offers a more sustainable way to reduce, reuse and recycle in one bottle ROCHESTER, N.Y., March 2, 2021 /PRNewswire/... Read more

Gas Chromatography High-Resolution Mass Spectrometer Offers New Opportunities for Analytical Testing

Gas Chromatography High-Resolution Mass Spectrometer Offers New Opportunities for Analytical Testing The Thermo Scientific Orbitrap Exploris GC Mass Spectrometer simplifies operations, delivers consistently accurate results and expands analytical capability AUSTIN, Texas, March 1, 2021 /PRNewswire/ — Analytical testing laboratories performing high-throughput analysis in the food safety, environmental, pharmaceutical, anti-doping and forensic toxicology sectors can benefit from a... Read more

New Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurements and Deep Learning for 4D Proteomics

Measured more than a million collision cross sections (CCS) from whole-proteome digests of five organisms with trapped ion mobility spectrometry (TIMS) and parallel accumulation-serial fragmentation (PASEF) on several timsTOF Pro systems Large-scale CCS data from 360 LC-TIMS-MS/MS runs, processed with MaxQuant With CCS alignment, across 347,885 peptide CCS values measured in duplicate, the median coefficient... Read more

Danaher To Present At Cowen Healthcare Conference

WASHINGTON, Feb. 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Cowen Healthcare Conference on Monday, March 1, 2021 at 11:40 a.m. ET. The video will be simultaneously webcast on www.danaher.com.  ABOUT DANAHERDanaher is a global science and technology innovator committed... Read more

Illumina and the University Hospital of Tübingen Evaluate Potential of Whole Genome Sequencing to Improve Diagnosis of Full Range of Genetic Diseases

TÜBINGEN, Germany–(BUSINESS WIRE)–February 19, 2021 — Illumina, Inc. (Nasdaq: ILMN) today announced an agreement with the Institute of Medical Genetics and Applied Genomics at the University Hospital of Tübingen to assess the value of whole-genome sequencing (WGS) as a first-line diagnostic test for patients with genetic diseases and familial cancer syndromes. Illumina will support the... Read more

Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

MENLO PARK, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Labcorp (NYSE: LH), a leading global life sciences company, has increased its commitment to highly accurate HiFi sequencing with the addition of new PacBio® Sequel® II Systems. The... Read more

Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19

MENLO PARK, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Labcorp (NYSE: LH), a leading global life sciences company, has increased its commitment to highly accurate HiFi sequencing with the addition of new PacBio® Sequel® II Systems. The... Read more